This is a preview of subscription content, log in via an institution to check access.
References
Kirkpatrick B, Buchanan RW, McKenney PD, et al.: The Schedule for the Deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 1989, 30:119–123.
Ressler KJ, Rothbaum BO, Tannenbaum L, et al.: Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004, 61:1136–1144.
Bell MD, Fiszdon J, Bryson G, Wexler BE: Effects of neurocognitive enhancement therapy in schizophrenia: normalisation of memory performance. Cogn Neuropsychiatry 2004, 9:199–211.
Greig TC, Zito W, Wexler BE, et al.: Improved cognitive function in schizophrenia after one year of cognitive training and vocational services. Schizophr Res 2007, 96:156–161.
De Hert MA, van Winkel R, Van Eyck D, et al.: Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr Res 2006, 83:87–93.
Rights and permissions
About this article
Cite this article
Cubells, J.F. Clinical trials report. Curr Psychiatry Rep 10, 137–139 (2008). https://doi.org/10.1007/s11920-008-0024-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11920-008-0024-3